ARTICLE IN PRESS / Janssen Pharmaceutica NV / Elsevier Ltd. / nn co / /
Country
Belgium / United States / /
Currency
pence / USD / / /
Event
FDA Phase / Diplomatic Relations / /
Facility
Rutgers University / / /
IndustryTerm
active site / dNTP-binding site / low energy conformations / polymerase active site / chemical environment / chemical steps / Chemical structures / hydrophobic binding site / chemical compositions / chemical composition / treatment of HIV / catalytic site / chemical diversity / chemical step / chemical classes / chemical / chemical bonds / /
MedicalCondition
HIV / HIV infection / advanced HIV infection / AIDS / infection / /
MedicalTreatment
Highly active antiretroviral therapy / HAART / /
Organization
Rutgers University / Department of Chemistry and Chemical Biology / Center for Advanced Biotechnology and Medicine / United Nations / NIH National Cancer Institute / /
Person
Van Herrewege / Reverse / Van Vaerenbergh / Paul Janssen / Stephen H. Hughesc / Paul J. Lewib / Frederick / Eddy Arnolda / / /
doi:[removed]j.pbiomolbio[removed]